title: Treatment of congenital aortic valve stenosis: impact of the Ross operation.
abstract: OBJECTIVE
  To evaluate the impact of the Ross operation, recently (1997) introduced in our unit, for the treatment of patients with congenital aortic valve stenosis.
  
  
  METHODS
  The period from January 1997 to December 2000 was compared with the previous 5 years (1992-96). Thirty-seven children (< 16 yrs) and 49 young adults (16-50 yrs) with congenital aortic valve stenosis underwent one of these treatments: percutaneous balloon dilatation (PBD), aortic valve commissurotomy, aortic valve replacement and the Ross operation. The Ross operation was performed in 16 patients, mean age 24.5 yrs (range 9-46 yrs) with a bicuspid stenotic aortic valve, 7/10 adults with calcifications, 2/10 adults with previous aortic valve commissurotomy, 4/6 children with aortic regurgitation following PBD, and 1/6 children who had had a previous aortic valve replacement with a prosthetic valve and aortic root enlargement.
  
  
  RESULTS
  PBD was followed by death in two neonates (fibroelastosis); all other children survived PBD. Although there were no deaths, PBD in adults was recently abandoned, owing to unfavourable results. Aortic valve commissurotomy showed good results in children (no deaths). Aortic valve replacement, although associated with good results (no deaths), has been recently abandoned in children in favour of the Ross operation. Over a mean follow-up of 16 months (2-40 months) all patients are asymptomatic following Ross operation, with no echocardiographic evidence of aortic valve regurgitation in 10/16 patients and with trivial regurgitation in 6/16 patients.
  
  
  CONCLUSIONS
  The approach now for children and young adults with congenital aortic valve stenosis should be as follows: (1) PBD is the first choice in neonates and infants; (2) Aortic valve commissurotomy is the first choice for children, neonates and infants after failed PBD; (3) The Ross operation is increasingly used in children after failed PBD and in young adults, even with a calcified aortic valve.
authors.affiliation: Service de chirurgie cardio-vasculaire, Centre Hospitalier Universitaire Vaudois, Lausanne, Suisse. antonio.corno@chuv.hospvd.ch
authors.forename: A F
authors.initials: AF
authors.lastname: Corno
authors.forename: J J
authors.initials: JJ
authors.lastname: Goy
authors.forename: M
authors.initials: M
authors.lastname: Hurni
authors.forename: M
authors.initials: M
authors.lastname: Payot
authors.forename: N
authors.initials: N
authors.lastname: Sekarski
authors.forename: L K
authors.initials: LK
authors.lastname: von Segesser
mesh_terms: D000293:Adolescent; D000328:Adult; D001024:Aortic Valve Stenosis / Q000151:congenital* / Q000601:surgery; D002648:Child; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011664:Pulmonary Valve / Q000637:transplantation*; D012086:Reoperation; D012189:Retrospective Studies; D014182:Transplantation, Autologous; D016896:Treatment Outcome